INMB
INMB
NASDAQ · Biotechnology

Inmune Bio Inc

$2.00
-0.03 (-1.48%)
As of Sep 28, 10:32 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +743.5% upside
Low Target $11.09
Average Target $16.87
High Target $25.84
Current Price $2.00
Current
$2.00
Target
$16.87
$11.09 $16.87 avg $25.84
Scenario Analysis
Bear Case
$11.09
454.5%
Low target
Base Case
$16.87
+743.5%
Avg target
Bull Case
$25.84
+1,192.0%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$2.60
-23.1% from high
52-Week Low
$1.09
+83.5% from low
Target vs 52W High
$16.87
+548.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%